Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism
Authors
Kapoor, AlokLandyn, Valentina
Wagner, Joann L.
Burgwinkle, Pamela
Huang, Wei
Gore, Joel M.
Spencer, Frederick A.
Goldberg, Robert
McManus, David D.
Darling, Chad E.
Boudreaux, Edwin D
Barton, Bruce A.
Mazor, Kathleen M.
UMass Chan Affiliations
Department of Population and Quantitative Health SciencesDepartment of Emergency Medicine
Department of Medicine, Division of Cardiovascular Medicine
Meyers Primary Care Institute
Document Type
Journal ArticlePublication Date
2020-12-01Keywords
venous thromboembolismanticoagulation
care transitions
clinical pharmacology
medication safety
patient education
Cardiology
Cardiovascular Diseases
Health Services Administration
Health Services Research
Patient Safety
Pharmacy and Pharmaceutical Sciences
UMCCTS funding
Metadata
Show full item recordAbstract
OBJECTIVE: The aim of the study was to assess the feasibility, satisfaction, and effectiveness of a care transition intervention with pharmacist home visit and subsequent anticoagulation expert consultation for patients with new episode of venous thromboembolism within a not-for-profit health care network. METHODS: We randomized patients to the intervention or control. During the home visit, a clinical pharmacist assessed medication management proficiency, asked open-ended questions to discuss knowledge gaps, and distributed illustrated medication instructions. Subsequent consultation with anticoagulation expert further filled knowledge gaps. At 30 days, we assessed satisfaction with the intervention and also measured the quality of care transition, knowledge of anticoagulation and venous thromboembolism, and anticoagulant beliefs (level of agreement that anticoagulant is beneficial, is worrisome, and is confusing/difficult to take). RESULTS: The mean +/- SD time required to conduct home visits was 52.4 +/- 20.5 minutes and most patients agreed that the intervention was helpful. In general, patients reported a high-quality care transition including having been advised of safety issues related to medications. Despite that, the mean percentage of knowledge items answered correctly among patients was low (51.5 versus 50.7 for intervention and controls, respectively). We did not find any significant difference between intervention and control patients for care transition quality, knowledge, or anticoagulant beliefs. CONCLUSIONS: We executed a multicomponent intervention that was feasible and rated highly. Nevertheless, the intervention did not improve care transition quality, knowledge, or beliefs. Future research should examine whether alternate strategies potentially including some but not all components of our intervention would be more impactful.Source
Kapoor A, Landyn V, Wagner J, Burgwinkle P, Huang W, Gore J, Spencer FA, Goldberg R, McManus DD, Darling C, Boudreaux E, Barton B, Mazor KM. Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism. J Patient Saf. 2020 Dec;16(4):e367-e375. doi: 10.1097/PTS.0000000000000571. PMID: 30702452; PMCID: PMC7678649. Link to article on publisher's site
DOI
10.1097/PTS.0000000000000571Permanent Link to this Item
http://hdl.handle.net/20.500.14038/41719PubMed ID
30702452Related Resources
Rights
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBYNC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.Distribution License
http://creativecommons.org/licenses/by-nc-nd/4.0/ae974a485f413a2113503eed53cd6c53
10.1097/PTS.0000000000000571
Scopus Count
Except where otherwise noted, this item's license is described as Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBYNC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.